Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells

Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells

Abstract Background Resistance to platinum-based chemotherapy is one of the crucial problems in ovarian cancer treatment. Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression. The aim of this study is to determine whether ghrelin influences the sensitivity of...

Full description

Bibliographic Details
Main Authors: Yun Leng, Can Zhao, Guoliang Yan, Shuangyue Xu, Yinggui Yang, Ting Gong, Xin Li, Chenglin Li
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Journal of Ovarian Research
Subjects:
Ghrelin
Cisplatin
Ovarian cancer
Cell cycle
S phase arrest
CDK1
Online Access:https://doi.org/10.1186/s13048-021-00907-9

Internet

https://doi.org/10.1186/s13048-021-00907-9

Similar Items